Schneyer Mark C.
SEC CIK 1899977 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | EVP, CFO | 82.1K | — | $3.38M | 51 | 2022-02-23 | 2026-08-05 |
Most active insiders at ACAD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schneyer Mark C. | EVP, CFO | — | $1.13M |
| 2 | Daly James M | Dir | — | $671.1K |
| 3 | Kihara James | PRINCIPAL ACCOUNTING Off | — | $602.8K |
| 4 | Thompson Elizabeth H.Z. | EVP, Head of Research, Dev | — | $506.4K |
| 5 | Owen Adams Catherine | CEO, Dir | — | $249.9K |
| 6 | Rhodes Jennifer J | EVP, CLO, SEC | — | $245.0K |
| 7 | Ndu Adora | Dir | — | — |
| 8 | GAROFALO ELIZABETH A. | Dir | — | — |
| 9 | Poole Jonathan | Dir | — | — |
| 10 | Brege Laura | Dir | — | — |
Transactions 51
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-07 18:00 | 2026-08-05+ | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | $17.84 | +20.1K | 82.1K | +32% | +$359.3K |
| DMT | 2026-08-07 18:00 | 2026-08-05+ | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $29.16 | -20.1K | 67.8K | -23% | -$587.2K |
| D | 2026-05-05 18:00 | 2026-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +6,815 | 69.7K | +11% | — |
| D | 2026-05-05 18:00 | 2026-05-04 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $21.79 | -3,506 | 66.1K | -5% | -$76.4K |
| D | 2026-04-07 19:57 | 2026-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +5,276 | 65.5K | +9% | — |
| D | 2026-04-07 19:57 | 2026-04-07 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $22.20 | -2,709 | 62.8K | -4% | -$60.1K |
| DM | 2026-03-26 | 2026-03-24+ | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +14.3K | 61.5K | +30% | — |
| DM | 2026-03-26 | 2026-03-25+ | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $21.55 | -7,385 | 57.3K | -11% | -$159.1K |
| DM | 2025-11-19 | 2025-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +19.8K | 63.6K | +45% | — |
| D | 2025-11-19 | 2025-11-18 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $23.69 | -10.3K | 53.3K | -16% | -$243.1K |
| 2025-09-16 | 2025-09-12 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | A - Grant | $0.00 | +6,815 | 46.9K | +17% | $0 | |
| 2025-09-16 | 2025-09-15 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale | $23.65 | -3,498 | 43.4K | -7% | -$82.7K | |
| 2025-08-19 | 2025-08-18 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale | $25.18 | -22.0K | 40.1K | -35% | -$554.0K | |
| 2025-05-19 | 2025-05-16 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale | $25.00 | -2,000 | 62.1K | -3% | -$50.0K | |
| D | 2025-05-02 | 2025-05-02 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $14.60 | -3,498 | 62.8K | -5% | -$51.1K |
| D | 2025-05-02 | 2025-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +6,815 | 66.3K | +11% | — |
| D | 2025-04-08 | 2025-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +5,275 | 62.2K | +9% | — |
| D | 2025-04-08 | 2025-04-08 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $14.82 | -2,708 | 59.5K | -4% | -$40.1K |
| D | 2025-03-26 | 2025-03-25 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +6,178 | 60.1K | +11% | — |
| D | 2025-03-26 | 2025-03-26 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $17.05 | -3,171 | 56.9K | -5% | -$54.1K |
| D | 2025-02-25 | 2025-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +1,353 | 54.7K | +3% | — |
| D | 2025-02-25 | 2025-02-24 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $19.96 | -773 | 53.9K | -1% | -$15.4K |
| D | 2024-11-19 | 2024-11-19 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $16.81 | -10.3K | 53.3K | -16% | -$172.5K |
| DM | 2024-11-19 | 2024-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +19.8K | 53.6K | +59% | — |
| 2024-08-20 | 2024-08-19 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale | $15.28 | -9,733 | 43.7K | -18% | -$148.7K | |
| M | 2024-08-20 | 2024-08-16 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | A - Grant | $0.00 | +18.9K | 39.8K | +90% | $0 |
| D | 2024-06-11 | 2024-06-10 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $14.79 | -975 | 34.6K | -3% | -$14.4K |
| D | 2024-06-11 | 2024-06-08 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +1,893 | 35.5K | +6% | — |
| D | 2024-05-03 | 2024-05-02 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $16.94 | -3,503 | 32.1K | -10% | -$59.3K |
| D | 2024-05-03 | 2024-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +6,814 | 35.6K | +24% | — |
| D | 2024-04-09 | 2024-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +5,275 | 31.5K | +20% | — |
| D | 2024-04-09 | 2024-04-08 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $17.87 | -2,716 | 28.7K | -9% | -$48.5K |
| D | 2024-03-27 | 2024-03-25 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | A - Grant | $0.00 | +10.6K | 31.6K | +50% | $0 |
| D | 2024-03-27 | 2024-03-27 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale | $17.90 | -5,434 | 26.2K | -17% | -$97.3K |
| D | 2024-02-27 | 2024-02-26 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $24.67 | -772 | 21.1K | -4% | -$19.0K |
| D | 2024-02-27 | 2024-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +1,353 | 21.8K | +7% | — |
| DM | 2023-11-21 | 2023-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +9,912 | 25.6K | +63% | — |
| D | 2023-11-21 | 2023-11-20 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $22.64 | -5,108 | 20.5K | -20% | -$115.6K |
| 2023-08-23 | 2023-08-21 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale | $29.00 | -10.0K | 15.7K | -39% | -$290.0K | |
| D | 2023-06-12 | 2023-06-08 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $25.02 | -974 | 22.8K | -4% | -$24.4K |
| D | 2023-06-12 | 2023-06-08 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | $0.00 | +1,893 | 23.8K | +9% | $0 |
| DM | 2023-05-19 | 2023-05-17 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +29.7K | 37.2K | +398% | — |
| D | 2023-05-19 | 2023-05-17 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $22.50 | -15.3K | 21.9K | -41% | -$344.5K |
| D | 2023-04-07 | 2023-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +5,275 | 9,393 | +128% | — |
| D | 2023-04-07 | 2023-04-06 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $18.16 | -1,916 | 7,477 | -20% | -$34.8K |
| D | 2023-02-27 | 2023-02-24 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $18.78 | -577 | 4,118 | -12% | -$10.8K |
| D | 2023-02-27 | 2023-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | — | +1,353 | 4,695 | +40% | — |
| D | 2022-06-10 | 2022-06-08 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | M - OptEx | $0.00 | +1,893 | 3,995 | +90% | $0 |
| D | 2022-06-10 | 2022-06-09 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $17.91 | -653 | 3,342 | -16% | -$11.7K |
| D | 2022-02-25 | 2022-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | CFO | M - OptEx | $0.00 | +1,352 | 2,655 | +104% | $0 |
| D | 2022-02-25 | 2022-02-23 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | CFO | S - Sale+OE | $23.80 | -553 | 2,102 | -21% | -$13.2K |
Purchase Sale Sale after option exercise All abbreviations